Sana Biotechnology, Inc.SANANASDAQ

|||

Switch Symbol:

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 82% recommend buying.

Consensus Rating

Buy

11 analysts·Moderate coverage

82%

Rating Distribution

Strong Buy

00%

Buy

982%

Hold

218%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 125% higher.

Bear Case

$8.00

+125%

Consensus

$8.00

+125%

Bull Case

$8.00

+125%

Price Range11 analysts

Low

Consensus

High

$8.00

Current Target

Current Price

$3.55

Upside to Target

$4.45

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.56(6 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev—

EPS—

FY2028

Rev+184.89%

EPS—

FY2029

Rev-74.87%

EPS—

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+1.9%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Oct 30, 2025JMP Securities

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

Target:$8.00

+49.0%from $5.37

Nov 5, 2024H.C. Wainwright

Sana Biotechnology (SANA) PT Lowered to $8 at H.C. Wainwright

Target:$8.00

+136.0%from $3.39

Jan 16, 2024H.C. Wainwright

H.C. Wainwright Upgrades Sana Biotechnology (SANA) to Buy

Target:$12.00

+88.7%from $6.36

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance